Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

COVID-19: Optimising supportive care during active cancer treatment

Dr Paul Cornes - Comparative Outcomes Group, Bristol, UK

COVID-19: Optimising supportive care during active cancer treatment ( Dr Paul Cornes - Comparative Outcomes Group, Bristol, UK )

Perioperative novel systemic immunotherapy-based approaches in urinary cancers

Dr Shilpa Gupta - Cleveland Clinic, Cleveland, USA

Perioperative novel systemic immunotherapy-based approaches in urinary cancers ( Dr Shilpa Gupta - Cleveland Clinic, Cleveland, USA )

ASCO 2020: Updates in renal cancer

Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA

ASCO 2020: Updates in renal cancer ( Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA )

TROPHIMMUN: Avelumab for gestational trophoblastic tumours resistant to...

Prof Benoit You - Hospices Civils de Lyon, Lyon, France

TROPHIMMUN: Avelumab for gestational trophoblastic tumours resistant to monochemotherapy ( Prof Benoit You - Hospices Civils de Lyon, Lyon, France )

KEYNOTE-177 results: Pembrolizumab versus chemotherapy for patients with MSI-H...

Prof Thierry Andre - Sorbonne University and Saint-Antoine Hospital, Paris...

KEYNOTE-177 results: Pembrolizumab versus chemotherapy for patients with MSI-H/dMMR colorectal cancer ( Prof Thierry Andre - Sorbonne University and Saint-Antoine Hospital, Paris, France )

Highlights from ASCO 2020

Dr Bishal Gyawali - Queen's University, Kingston, Canada

Highlights from ASCO 2020 ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )

PARP inhibitors in prostate cancer: Guidelines, who to test and the patient...

Dr Neal Shore and Dr Elena Castro

PARP inhibitors in prostate cancer: Guidelines, who to test and the patient pathway ( Dr Neal Shore and Dr Elena Castro )

New emerging treatment options and targeted therapies for bladder cancer

Dr Arlene Siefker-Radtke and Dr Yohann Loriot

New emerging treatment options and targeted therapies for bladder cancer ( Dr Arlene Siefker-Radtke and Dr Yohann Loriot )

Conducting Oncology Clinical Trials in Africa II: ACTC Informational Session

Prof Folakemi Odedina, Prof Ifeoma Okoye and Prof Delva Shamley

Conducting Oncology Clinical Trials in Africa II: ACTC Informational Session ( Prof Folakemi Odedina, Prof Ifeoma Okoye and Prof Delva Shamley )

Timing of response to venetoclax combination treatment in older patients with...

Dr Brian Jonas - University of California Davis Comprehensive Cancer Center...

Timing of response to venetoclax combination treatment in older patients with acute myeloid leukaemia ( Dr Brian Jonas - University of California Davis Comprehensive Cancer Center, Sacramento, USA )

CheckMate 227 three-year update: Nivolumab plus ipilimumab versus chemo as...

Prof Suresh Ramalingam - Winship Cancer Institute of Emory University, Atlanta...

CheckMate 227 three-year update: Nivolumab plus ipilimumab versus chemo as first-line treatment for advanced NSCLC ( Prof Suresh Ramalingam - Winship Cancer Institute of Emory University, Atlanta, USA )

Conducting Oncology Clinical Trials in Africa II: Practical steps for...

Dr Victoria Olaiya - Synteract, UK

Conducting Oncology Clinical Trials in Africa II: Practical steps for conducting clinical trials in Africa ( Dr Victoria Olaiya - Synteract, UK )

More from ecancer